NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Lobe Sciences Ltd (CN: LOBE)
LOBE Technical Analysis
4
As on 3rd Feb 2025 LOBE STOCK Price closed @ 0.02 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.02 & Strong Sell for SHORT-TERM with Stoploss of 0.02 we also expect STOCK to react on Following IMPORTANT LEVELS. |
LOBESTOCK Price
Open | 0.02 | Change | Price | % |
High | 0.02 | 1 Day | 0.00 | 0.00 |
Low | 0.02 | 1 Week | 0.00 | 0.00 |
Close | 0.02 | 1 Month | 0.00 | 0.00 |
Volume | 33298 | 1 Year | -0.01 | -33.33 |
52 Week High 0.04 | 52 Week Low 0.01 |
CN Canada Most Active Stocks
PUMP | 0.01 | 0.00% |
BIGG | 0.22 | 15.79% |
HODL | 4.55 | 5.57% |
ACDC | 0.06 | 0.00% |
TRIP | 0.04 | 0.00% |
FMAN | 0.55 | 7.84% |
PKK | 0.04 | 0.00% |
TER | 2.80 | 5.66% |
RVV | 0.01 | 0.00% |
GSK | 0.54 | 20.00% |
CN Canada Top Gainers Stocks
CN Canada Top Losers Stocks
LOBE Daily Charts |
LOBE Intraday Charts |
Whats New @ Bazaartrend |
LOBE Free Analysis |
|
LOBE Important Levels Intraday
RESISTANCE | 0.02 |
RESISTANCE | 0.02 |
RESISTANCE | 0.02 |
RESISTANCE | 0.02 |
RESISTANCE | 0.02 |
RESISTANCE | 0.02 |
RESISTANCE | 0.02 |
RESISTANCE | 0.02 |
LOBE Forecast February 2025
4th UP Forecast | 0.04 |
3rd UP Forecast | 0.03 |
2nd UP Forecast | 0.03 |
1st UP Forecast | 0.03 |
1st DOWN Forecast | 0.01 |
2nd DOWN Forecast | 0.01 |
3rd DOWN Forecast | 0.01 |
4th DOWN Forecast | 0 |
LOBE Weekly Forecast
4th UP Forecast | 0.04 |
3rd UP Forecast | 0.03 |
2nd UP Forecast | 0.03 |
1st UP Forecast | 0.03 |
1st DOWN Forecast | 0.01 |
2nd DOWN Forecast | 0.01 |
3rd DOWN Forecast | 0.01 |
4th DOWN Forecast | 0.00 |
LOBE Forecast2025
4th UP Forecast | 0.08 |
3rd UP Forecast | 0.06 |
2nd UP Forecast | 0.05 |
1st UP Forecast | 0.04 |
1st DOWN Forecast | 0 |
2nd DOWN Forecast | -0.01 |
3rd DOWN Forecast | -0.02 |
4th DOWN Forecast | -0.04 |
Lobe Sciences Ltd ( CN Canada Symbol : LOBE )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
LOBE Other Details
Segment | EQ | |
Market Capital | 12354870.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
LOBE Address
LOBE Latest News
LOBE Business Profile
Lobe Sciences Ltd., a technology and services company, provides real estate, financial, management, intellectual property, and branding support for development of transformational medicine in the United States. The company intends to develop psilocybin-based therapeutics for the treatment of mild traumatic brain injuries and post-traumatic stress disorder and devices for the efficient application of medications. It also owns acquired brands, intellectual property, and leases office and production premises to a cannabis processor and retailer. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. is headquartered in Vancouver, Canada. Address: 1199 West Hastings Street, Vancouver, BC, Canada, V6E 3T2
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service